Exabis Library
Welcome to the e-CCO Library!
P001: Obefazimod upregulates miR-124 and downregulates the expression of some cytokines in blood and rectal biopsies of patients with moderate-to-severe ulcerative colitis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P001: Succinate, a gut microbiota-derived metabolite, modulates the inflammatory status of the creeping fat in Crohn’s disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P001: The biomarker profile of PTG-200, an oral peptide antagonist of IL-23 receptor, tracks with efficacy in a preclinical model of IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P002 Specific genome editing to model hypermethylation of the SP140 gene that associates to Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0020: Type 1 and CD103+ type 2 conventional dendritic cells are decreased in patients with active ulcerative colitis but not with Crohn’s disease.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0021: Long non-coding RNAs as predictors of response to anti-TNF therapy in Ulcerative Colitis patients
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0022: Development of primary human fibroblast cell cultures for fibrosis modelling in Inflammatory Bowel Diseases
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0023: Methionine Restriction Promotes Intestinal Mucosal Repair by Regulating Selenbp1 and Modulating Macrophage Polarization
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0024: Circadian regulator-mediated molecular subtypes depict the features of elderly ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0025: The effect of very small superparamagnetic nanoparticles on human blood cells as a diagnostic tool in Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0026: Multi-omics phenotyping characterizes perturbed molecular divergence underlying different clinical scenarios of under-treatment inflammatory bowel disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0027: The carbon footprint of remote monitoring of IBD patients – a green opportunity for sustainable outpatient care
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0028: Discovery of GLP-2R agonists using computational molecular design techniques
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0029: Abnormal glycerophospholipid metabolism in CCL2+DPP4+ mesenchymal stem cells may contributes to creeping fat fibrosis in Crohn's Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P002: Beneficial effects of blocking EphBs-ephrinBs forward signalling in a murine Crohn’s sisease (CD) model
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P002: Endoscopic placement of a drug-eluting platform with monoclonal antibodies in an animal model of experimental colitis by TNBS: effect on disease outcome and anti-drug antibodies (ADA’s) formation
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P002: Epithelial to mesenchymal transition is a hallmark of fibrostenosing Crohn’s disease and is associated with down regulation of the miR-200 family
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P002: Exclusive Enteral Nutrition, the gut microbiome and corticosteroid response in patients with acute severe colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P002: Glial cell line-Derived Neurotrophic Factor (GDNF) improves intestinal wound healing – A new target for IBD treatment?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P002: Inhibition of Axl signaling by BGB324 reduces fibrogenesis in human intestinal cells and human intestinal organoids
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM